Results 101 to 110 of about 21,795 (202)

Hereditary Transthyretin Amyloid Cardiomyopathy [PDF]

JAMA Cardiology, 2022
Quentin R, Youmans, Sanjiv J, Shah, Sadiya S, Khan   +2 more
openaire   +2 more sources

Transthyretin [PDF]

, 2019
openaire   +1 more source

Validity of Amyloidosis in the Danish National Patient Registry. [PDF]

Clin Epidemiol
Skov JK, Sikandar U, Bonnesen K, Poulsen SH, Schmidt M.   +4 more
europepmc   +1 more source

Pittsburgh compound B positron emission tomography detects cardiomyopathy in hereditary transthyretin amyloidosis patients with negative bone scintigraphy: a pilot study. [PDF]

Front Nucl Med
Tingen HSA, Stormezand GN, van Snick P, Hu Y, Van Der Zwaag P, Oerlemans M, van der Meer P, Hazenberg BPC, Luurtsema G, Nienhuis HLA, Slart RHJA.   +10 more
europepmc   +1 more source

Autonomic dysfunction in patients with wild-type transthyretin amyloidosis. [PDF]

J Neurol
Kleinveld VEA, Wanschitz J, Hotter A, Horlings CGC, Leys F, Ungericht M, Pölzl G, Granata R, Fanciulli A, Löscher WN.   +9 more
europepmc   +1 more source

Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis. [PDF]

Circ Heart Fail
Zampieri M, Biagioni G, Del Franco A, Canepa M, Porto I, Zanoletti M, Labate ME, Porcari A, Bordignon L, Merlo M, Sinagra G, Tini G, Musumeci B, Barbato E, Autore C, Biagini E, Longhi S, Sena G, Ponziani A, Saturi G, Fico V, Argirò A, Mazzoni C, Fumagalli C, Olivotto I, Perfetto F, Cappelli F.   +26 more
europepmc   +1 more source

Transthyretin cardiac amyloidosis in Saudi Arabia and the Middle East: insights, projected prevalence and practical applications

Frontiers in Cardiovascular Medicine, 2023
Dania Mohty, Dania Mohty, Mohamed H. Omer, Omar Ahmad, Islam Alayary, Talal Alzahrani, Thibaud Damy, Bahaa Fadel, Bahaa Fadel   +8 more
doaj   +1 more source

Transthyretin (TTR) [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

Transthyretin Cardiac Amyloidosis With Reduced Ejection Fraction in a 47-Year-Old Man: An Unusual Presentation. [PDF]

Cureus
Moujahid M, Allalat I, Lamtai M, Fellat N.   +3 more
europepmc   +1 more source

Evaluation of Cleavable Crosslinking for Characterization of Proteoform Structural Differences by Top-Down Mass Spectrometry. [PDF]

Int J Mass Spectrom
Renbarger EA, Webb IK.
europepmc   +1 more source